Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry.

cardiac implantable electronic device complications device infection lead dislodgement lead failure pneumothorax pocket hematoma

Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
04 2020
Historique:
received: 05 08 2019
revised: 13 11 2019
accepted: 13 11 2019
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 19 8 2021
Statut: ppublish

Résumé

This study aimed to determine how CIED-related complications affect all-cause and cardiovascular mortality over a long-term follow-up. Although complications related to implantable electronic device (CIED) implantation are steadily increasing in Europe, little is known about the impact of complications other than device infection on mortality. The POINTED (Impact on Patient Outcome and health care utilization of cardiac ImplaNTable Electronic Device complications) registry was a prospective, multicenter, observational study designed to collect data on complications in patients undergoing de novo CIED implantation (NCT03612635). All consecutive patients were enrolled in 6 high-volume centers between January 2010 and December 2012 and followed up for at least 3 years. A complication was defined as any CIED-related adverse event requiring surgical revision after implantation. During follow-up (median 56.9 months), we observed 283 complications in 263 of 2811 consecutive patients (71 ± 14 years of age, 66.7% men). Early complications (≤30 days) were associated with significantly lower cumulative survival from cardiovascular death in comparison with late complications and with freedom from complications. On multivariate analysis, early complication, pneumothorax, and pocket hematoma were significantly associated with a higher risk of all-cause death, while device infection remained the only complication significantly associated with a higher risk of cardiovascular death. All CIED-related complications are associated with an increased risk of cardiovascular mortality, and early complications are associated with an increased risk of all-cause mortality. These data underline the importance of specific measures aimed at reducing CIED complications and improving their management.

Sections du résumé

OBJECTIVES
This study aimed to determine how CIED-related complications affect all-cause and cardiovascular mortality over a long-term follow-up.
BACKGROUND
Although complications related to implantable electronic device (CIED) implantation are steadily increasing in Europe, little is known about the impact of complications other than device infection on mortality.
METHODS
The POINTED (Impact on Patient Outcome and health care utilization of cardiac ImplaNTable Electronic Device complications) registry was a prospective, multicenter, observational study designed to collect data on complications in patients undergoing de novo CIED implantation (NCT03612635). All consecutive patients were enrolled in 6 high-volume centers between January 2010 and December 2012 and followed up for at least 3 years. A complication was defined as any CIED-related adverse event requiring surgical revision after implantation.
RESULTS
During follow-up (median 56.9 months), we observed 283 complications in 263 of 2811 consecutive patients (71 ± 14 years of age, 66.7% men). Early complications (≤30 days) were associated with significantly lower cumulative survival from cardiovascular death in comparison with late complications and with freedom from complications. On multivariate analysis, early complication, pneumothorax, and pocket hematoma were significantly associated with a higher risk of all-cause death, while device infection remained the only complication significantly associated with a higher risk of cardiovascular death.
CONCLUSIONS
All CIED-related complications are associated with an increased risk of cardiovascular mortality, and early complications are associated with an increased risk of all-cause mortality. These data underline the importance of specific measures aimed at reducing CIED complications and improving their management.

Identifiants

pubmed: 32327071
pii: S2405-500X(19)30914-4
doi: 10.1016/j.jacep.2019.11.005
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-392

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Auteurs

Pietro Palmisano (P)

Cardiology Unit, "Card. Giovanni Panico" Hospital, Tricase, Italy. Electronic address: dr.palmisano@libero.it.

Federico Guerra (F)

Cardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital Umberto I-Lancisi-Salesi, Ancona, Italy.

Gabriele Dell'Era (G)

Division of Cardiology, University Hospital Maggiore della Carità, University of Eastern Piedmont, Novara, Italy.

Ernesto Ammendola (E)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Matteo Ziacchi (M)

Institute of Cardiology, University of Bologna, Sant'Orsola-Malpighi University Hospital; Bologna, Italy.

Mattia Laffi (M)

Divisione Cardiologia, Ospedale Villa Scassi, Genova ASL 3, Genova, Italy.

Francesca Troiano (F)

Cardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital Umberto I-Lancisi-Salesi, Ancona, Italy.

Eleonora Prenna (E)

Division of Cardiology, University Hospital Maggiore della Carità, University of Eastern Piedmont, Novara, Italy.

Vincenzo Russo (V)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Andrea Angeletti (A)

Institute of Cardiology, University of Bologna, Sant'Orsola-Malpighi University Hospital; Bologna, Italy.

Alessandro Guido (A)

Cardiology Unit, "Card. Giovanni Panico" Hospital, Tricase, Italy.

Eraldo Occhetta (E)

Division of Cardiology, University Hospital Maggiore della Carità, University of Eastern Piedmont, Novara, Italy.

Gerardo Nigro (G)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Mauro Biffi (M)

Institute of Cardiology, University of Bologna, Sant'Orsola-Malpighi University Hospital; Bologna, Italy.

Germano Gaggioli (G)

Divisione Cardiologia, Ospedale Villa Scassi, Genova ASL 3, Genova, Italy.

Alessandro Capucci (A)

Cardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital Umberto I-Lancisi-Salesi, Ancona, Italy.

Michele Accogli (M)

Cardiology Unit, "Card. Giovanni Panico" Hospital, Tricase, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH